Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Invested Capital (2016 - 2018)

Historic Invested Capital for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $8.8 million.

  • Armata Pharmaceuticals' Invested Capital fell 984.93% to $8.8 million in Q3 2018 from the same period last year, while for Sep 2018 it was $8.8 million, marking a year-over-year decrease of 984.93%. This contributed to the annual value of $7.7 million for FY2017, which is 2048.75% down from last year.
  • Armata Pharmaceuticals' Invested Capital amounted to $8.8 million in Q3 2018, which was down 984.93% from $11.6 million recorded in Q2 2018.
  • Armata Pharmaceuticals' Invested Capital's 5-year high stood at $408.5 million during Q1 2018, with a 5-year trough of -$34.0 million in Q1 2014.
  • In the last 5 years, Armata Pharmaceuticals' Invested Capital had a median value of $9.7 million in 2016 and averaged $27.1 million.
  • In the last 5 years, Armata Pharmaceuticals' Invested Capital tumbled by 5410.07% in 2017 and then soared by 604417.87% in 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Invested Capital (Quarter) stood at $3.4 million in 2014, then skyrocketed by 269.92% to $12.7 million in 2015, then fell by 23.53% to $9.7 million in 2016, then fell by 20.49% to $7.7 million in 2017, then grew by 13.78% to $8.8 million in 2018.
  • Its Invested Capital was $8.8 million in Q3 2018, compared to $11.6 million in Q2 2018 and $408.5 million in Q1 2018.